Breast cancer risk associated with benign breast disease: systematic review and meta-analysis

Breast Cancer Research and Treatment

Volumn 149, Issue 3, 2015, Pages 569-575

  Dyrstad, Sara W ^a,b   Yan, Yan ^c   Fowler, Amy M ^a,d   Colditz, Graham A ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Odessa Medical Center   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Atypia; Benign breast disease; Breast cancer; Meta analysis

Indexed keywords

AGE; ATYPICAL DUCTAL HYPERPLASIA; ATYPICAL LOBULAR HYPERPLASIA; BENIGN BREAST DISEASE NOT OTHERWISE SPECIFIED; BREAST BIOPSY; BREAST CANCER; BREAST CYST; BREAST DISEASE; BREAST FIBROADENOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL EVALUATION; DISEASE ASSOCIATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; NONPROLIFERATIVE BREAST DISEASE; PRIORITY JOURNAL; PROLIFERATIVE BREAST DISEASE WITHOUT ATYPIA; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; BIOPSY; BREAST TUMOR; FEMALE; HYPERPLASIA; MEDLINE; META ANALYSIS; MIDDLE AGED; PATHOLOGY;

BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MIDDLE AGED; PUBMED; RISK FACTORS;

EID: 84925464634     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3254-6     Document Type: Review

References (54)

1. Silvera S, Rohan T (2008) Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat 110:397–409
2. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231–273
3. Lee S, Mohsin SK, Mao S, Hilsenbeck SG, Medina D, Allred DC (2006) Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res 8:R6
4. Berryhill GE, Gloviczki JM, Trott JF, Aimo L, Kraft J, Cardiff RD, Paul CT, Petrie WK, Lock AL, Hovey RC (2012) Diet-induced metabolic change induces estrogen-independent allometric mammary growth. Proc Natl Acad Sci USA 109:16294–16299
5. Su X, Tamimi RM, Collins LC, Baer HJ, Cho E, Sampson L, Willett WC, Schnitt SJ, Connolly JL, Rosner BA, Colditz GA (2010) Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control 21:1033–1046
6. Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Colditz GA (2011) Prospective study of growth and development in older girls and risk of benign breast disease in young women. Cancer 117:1612–1620
7. Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Rockett HR, Colditz GA (2010) Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics 125:e1081–e1087
8. Jung MM, Colditz GA, Collins LC, Schnitt SJ, Connolly JL, Tamimi RM (2011) Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control 22:1297–1305
9. Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Colditz GA (2012) Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics 129:e1192–e1198
10. Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WY, Willett WC, Tamimi RM (2013) Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst 105:1571–1578
11. Friedenreich C, Bryant H, Alexander F, Hugh J, Danyluk J, Page D (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29:637–644
12. Elmore JG, Gigerenzer G (2005) Benign breast disease—the risks of communicating risk. N Engl J Med 353:297–299
13. Krieger N, Hiatt RA (1992) Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 135:619–631
14. Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the nurses’ health study. Am J Epidemiol 152:950–964
15. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia. Cancer 109:180–187
16. Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698–2708
17. Dupont WD, Page DL (1987) Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 125:769–779
18. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477
19. Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64:1977–1983
20. Ashbeck EL, Rosenberg RD, Stauber PM, Key CR (2007) Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomark Prev 16:467–472
21. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG (1993) Prognostic significance of benign proliferative breast disease. Cancer 71:3896–3907
22. Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME, Page DL (2008) Histologic associations and long-term cancer risk in columnar cell lesions of the breast. Cancer 113:2415–2421
23. Dorjgochoo T, Deming S, Gao Y-T, Lu W, Zheng Y, Ruan Z, Zheng W, Shu X (2008) History of benign breast disease and risk of breast cancer among women in china: a case–control study. Cancer Causes Control 19:819–828
24. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS, Schuyler PA (1994) Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331:10–15
25. Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258–1265
26. Goldacre MJ, Abisgold JD, Yeates DG, Vessey MP (2010) Benign breast disease and subsequent breast cancer: English record linkage studies. J Public Health (Oxf) 32:565–571
27. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237
28. Helmrich SP, Shapiro S, Rosenberg L, Kaufman DW, Slone D, Bain C, Miettinen OS, Stolley PD, Rosenshein NB, Knapp RC, Leavitt T, Schottenfeld D, Engle RL, Levy M (1983) Risk factors for breast cancer. Am J Epidemiol 117:35–45
29. Hill DA, Preston-Martin S, Ross RK, Bernstein L (2002) Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA. Cancer Causes Control 13:711–718
30. Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B (1980) Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 65:13–20
31. Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE (2010) A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control 21:821–828
32. Levi F, Randimbison L, Te VC, La Vecchia C (1994) Incidence of breast cancer in women with fibroadenoma. Int J Cancer 57:681–683
33. Lewis JT, Hartmann LC, Vierkant RA, Maloney SD, Shane Pankratz V, Allers TM, Frost MH, Visscher DW (2006) An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 30:665–672
34. McDivitt RW, Stevensm JA, Lee NC, Wingo PA, Rubin GL, Gersell D (1992) Histologic types of benign breast disease and the risk for breast cancer. Cancer 69:1408–1414
35. Minami Y, Ohuchi N, Taeda Y, Takano A, Fukao A, Satomi S, Hisamichi S (1999) Risk of breast cancer in Japanese women with benign breast disease. Jpn J Cancer Res 90:600–606
36. Nomura Y, Tashiro H, Katsuda Y (1993) Benign breast disease as a breast cancer risk in Japanese women. Jpn J Cancer Res 84:938–944
37. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361:125–129
38. Palli D, Turco MRD, Simoncini R, Bianchi S (1991) Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer 47:703–706
39. Sakr R, Rouzier R, Salem C, Antoine M, Chopier J, Darai E, Uzan S (2008) Risk of breast cancer associated with papilloma. Eur J Surg Oncol 34:1304–1308
40. Shaaban AM, Sloane JP, West CR, Moore FR, Jarvis C, Williams EMI, Foster CS (2002) Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol 26:421–430
41. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96:616–620
42. Worsham MJ, Raju U, Lu M, Kapke A, Botttrell A, Cheng J, Shah V, Savera A, Wolman SR (2009) Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 118:1–7
43. Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR (2007) Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res 13:5474–5479
44. Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M (2001) Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 93:1791–1798
45. Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5–30
46. Begg C, Berlin J (1988) Publication bias: a problem in interpreting medical data. J R Stat Soc A 151:419–463
47. McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, Page DL (2006) Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer 107:1227–1233
48. Ghys R (1986) Natural history of benign and malignant breast tumors seen in a screening center. 15-year retrospective study. Cancer 57:1618–1626
49. Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM, Frost MH, Maloney SD, Reynolds C, Boughey JC (2008) Assessment of the accuracy of the gail model in women with atypical hyperplasia. J Clin Oncol 26:5374–5379
50. Tamimi RM, Rosner B, Colditz GA (2010) Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer 116:4944–4953
51. Khan SA, Rogers MAM, Khurana KK, Meguid MM, Numann PJ (1998) Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 90:37–42
52. Schnitt SJ (2001) Benign breast disease and breast cancer risk: potential role for antiestrogens. Clin Cancer Res 7:4419s–4422s discussion 4411s–4412s
53. Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B, Wolmark N (2003) Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. J Natl Cancer Inst 95:302–307
54. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM (2013) Use of pharmacologic interventions for breast cancer risk reduction: American society of clinical oncology clinical practice guideline. J Clin Oncol 31:2942–2962